Second or Third Line Nivolumab Versus First Line Nivolumab in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

被引:0
|
作者
Martinez Moreno, E. [1 ]
Irigoyen Medina, A. [1 ]
Alvarez Cabellos, R. [1 ]
Martinez, K. A. [1 ]
Santiago, J. [1 ]
Rivilla, M. [1 ]
Cardenas, J. D. [1 ]
Esteban, C. [1 ]
Trujillo, B. [1 ]
Rosero, A. [1 ]
Fernandez, L. [1 ]
Ramos, I. [1 ]
Ramos, A. [1 ]
Chacon, J. I. [1 ]
机构
[1] Hosp Virgen de La Salud, Oncol Med, Toledo, Spain
关键词
chemotherapy; NSCLC; immunotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.04-29
引用
收藏
页码:S536 / S537
页数:2
相关论文
共 50 条
  • [1] Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Rogado, J.
    Pacheco-Barcia, V.
    Fenor De la Maza, M. D.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Obispo, B.
    Mondejar, R.
    Ballesteros, A.
    Donnay, O.
    Colomer, R.
    Sanchez-Torres, J. M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1915 - S1916
  • [2] Nivolumab Experience in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC) in Toledo, Spain
    Martinez Moreno, E.
    Irigoyen Medina, A.
    Martinez Barroso, K.
    Borregon Rivilla, M.
    Alvarez Cabellos, R.
    Cardenas, J. D.
    Andrade Santiago, J.
    Burgueno Lorenzo, I.
    Trujillo Alba, B.
    Chacon Lopez-Muniz, J. I.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2430 - S2430
  • [3] The use of second or third line nivolumab in advanced non-small cell lung cancer: a west of Scotland experience
    Ali, C.
    Yahya, K.
    [J]. LUNG CANCER, 2018, 115 : S31 - S31
  • [4] Long-term outcomes with nivolumab in patients with previously treated advanced Non-Small Cell Lung Cancer (NSCLC)
    Thomas, M.
    Kohlhaeufl, M.
    Reck, M.
    Engel-Riedel, W.
    Kortsik, C.
    Bullinger, L.
    Schneider, C. -P.
    Felip, E.
    Brahmer, J.
    Vokes, E.
    Gettinger, S.
    Geese, W.
    Yoon, D.
    Healey, D.
    Li, A.
    Eberhardt, W. E. E.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 137 - 137
  • [5] Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer and Liver Metastases
    Crino, L.
    Horn, L.
    Felip, E.
    Frontera, O. Aren
    Burgio, M.
    Waterhouse, D.
    Blumenschein, G.
    Barlesi, F.
    Garassino, M.
    Holgado, E.
    Antonia, S.
    Spigel, D.
    Gainor, J.
    Gettinger, S.
    Geese, W.
    Li, A.
    Healey, D.
    Ready, N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2302 - S2302
  • [6] Efficacy of second-line nivolumab after early time to progression on first-line cytotoxic chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)
    Ota, T.
    Kirita, K.
    Udagawa, H.
    Umemura, S.
    Matsumoto, S.
    Yoh, K.
    Niho, S.
    Goto, K.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [7] Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
    Gettinger, Scott
    Rizvi, Naiyer A.
    Chow, Laura Q.
    Borghaei, Hossein
    Brahmer, Julie
    Ready, Neal
    Gerber, David E.
    Shepherd, Frances A.
    Antonia, Scott
    Goldman, JonathanW.
    Juergens, Rosalyn A.
    Laurie, Scott A.
    Nathan, Faith E.
    Shen, Yun
    Harbison, Christopher T.
    Hellmann, Matthew D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 2980 - +
  • [8] Efficiency of nivolumab in the treatment of second-line advanced non-squamous non-small cell lung cancer (NSCLC) in Spain
    Gonzalez, P.
    Ortega-Joaquin, N.
    Provencio Pulla, M.
    Garrido, C.
    Echave, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [9] Feasibility Study of Nivolumab and Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Shimokawa, T.
    Nakamura, Y.
    Iwasawa, S.
    Miyazaki, K.
    Yamanaka, T.
    Takiguchi, Y.
    Okamoto, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2431 - S2431
  • [10] Feasibility study of nivolumab and docetaxel in previously treated patients with advanced non-small cell lung cancer
    Miyazaki, Kazuhito
    Iwasawa, Shunichiro
    Nakamura, Yukiko
    Shimokawa, Tsuneo
    Yamanaka, Takeharu
    Takiguchi, Yuichi
    Okamoto, Hiroaki
    [J]. ANNALS OF ONCOLOGY, 2017, 28